APA (7th ed.) Citation

GT, F., R, R., C, R., A, M., S, S., & UJ, M. (2018). Pharmacokinetics of glycopyrronium/formoterol fumarate dihydrate delivered via metered dose inhaler using co-suspension delivery technology in patients with moderate-to-very severe COPD. International journal of chronic obstructive pulmonary disease, 13, 945. https://doi.org/10.2147/COPD.S154988

Chicago Style (17th ed.) Citation

GT, Ferguson, Rodriguez-Roisin R, Reisner C, Maes A, Siddiqui S, and Martin UJ. "Pharmacokinetics of Glycopyrronium/formoterol Fumarate Dihydrate Delivered via Metered Dose Inhaler Using Co-suspension Delivery Technology in Patients with Moderate-to-very Severe COPD." International Journal of Chronic Obstructive Pulmonary Disease 13 (2018): 945. https://doi.org/10.2147/COPD.S154988.

MLA (9th ed.) Citation

GT, Ferguson, et al. "Pharmacokinetics of Glycopyrronium/formoterol Fumarate Dihydrate Delivered via Metered Dose Inhaler Using Co-suspension Delivery Technology in Patients with Moderate-to-very Severe COPD." International Journal of Chronic Obstructive Pulmonary Disease, vol. 13, 2018, p. 945, https://doi.org/10.2147/COPD.S154988.